Lewis Capital Management’s AbbVie ABBV Stock Holding History

Lewis Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$262K	Hold	1,760	–	–	0.41%	44
2023 Q2	$237K	Hold	1,760	–	–	0.34%	53
2023 Q1	$280K	Sell	1,760 -200	-10%	-$30.6K	0.42%	43
2022 Q4	$317K	Hold	1,960	–	–	0.48%	46
2022 Q3	$263K	Hold	1,960	–	–	0.4%	49
2022 Q2	$300K	Hold	1,960	–	–	0.43%	47
2022 Q1	$318K	Hold	1,960	–	–	0.36%	48
2021 Q4	$265K	Buy	+1,960	New	+$232K	0.28%	56

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lewis Capital Management's ABBV Position: Q3 2023 in Review

Lewis Capital Management held its AbbVie (ABBV) position steady in Q3 2023 at 1,760 shares worth $262K. The position accounts for 0.41% of the portfolio, ranked #44.

Lewis Capital Management first reported a position in ABBV in Q4 2021 and has held it in 8 quarters since. The position peaked at $318K in Q1 2022. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Lewis Capital Management held 1,760 shares of AbbVie worth $262K as of Q3 2023.
Lewis Capital Management left its AbbVie share count unchanged in Q3 2023.
AbbVie made up 0.41% of Lewis Capital Management's portfolio in Q3 2023, its #44 holding.
Lewis Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 8 quarters since.
Lewis Capital Management's AbbVie position peaked at $318K in Q1 2022.
3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Lewis Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.